| Thu, Jul 9, 2009 | | • | Alexion Pharmaceuticals to Report Second Quarter 2009 Results on July 23, 2009
Business Wire (Thu 10:00am)
| | Thu, Jul 2, 2009 | | • | Is IBB the Best Biotech ETF
at Seeking Alpha (Thu, Jul 2)
| | Wed, Jul 1, 2009 | | • | ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
EDGAR Online (Wed, Jul 1)
| | Sun, Jun 21, 2009 | | • | Fund manager likes Alexion, Micron, Pulte-Barron's
at Reuters (Sun, Jun 21)
| | Sat, Jun 20, 2009 | | • | This Week's 'Barron's Roundup'
at TheStreet.com (Sat, Jun 20)
| | • | [$$] Back in the Race
at Barron's Online (Sat, Jun 20)
| | Fri, Jun 19, 2009 | | • | Alexion Extends Its Commitment to a Green Footprint Through Its Ambitious New Solar Energy System
Business Wire (Fri, Jun 19)
| | Tue, Jun 16, 2009 | | • | Upcoming Rebalancing of the Russell Indices
at CNBC (Tue, Jun 16)
| | Thu, Jun 11, 2009 | | • | Handle Forms On Alexion's Shallow Cup
Investor's Business Daily (Thu, Jun 11)
| | Wed, Jun 10, 2009 | | • | Biotech Sector Expert Says Investors More Cautious
Wall Street Transcript (Wed, Jun 10)
| | • | Alexion's Soliris® Receives 2009 Prix Galien France for Most Innovative Drug for Rare Disease
Business Wire (Wed, Jun 10)
| | • | Alexion to Present at the Jefferies & Co. 3rd Annual Healthcare Conference
Business Wire (Wed, Jun 10)
| | Tue, Jun 9, 2009 | | • | Premarket roundup: Greif, Texas Instruments
AP (Tue, Jun 9)
| | • | Ahead of the Bell: Alexion Pharmaceuticals
AP (Tue, Jun 9)
| | Sun, Jun 7, 2009 | | • | New Research Presented at EHA Congress Shows That Soliris® Significantly Reduced Hemolysis in Never-Transfused Patients with PNH
Business Wire (Sun, Jun 7)
| | Wed, Jun 3, 2009 | | • | Alexion to Present at Investor Conferences
Business Wire (Wed, Jun 3)
| | Tue, Jun 2, 2009 | | • | ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Jun 2)
| | Fri, May 29, 2009 | | • | ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Fri, May 29)
| | Thu, May 28, 2009 | | • | Researchers to Report on the Investigational Use of Alexion's Soliris® (Eculizumab) to Prevent Antibody-Mediated Rejection in High-Risk Kidney Transplant Patients
Business Wire (Thu, May 28)
| | Fri, May 15, 2009 | | • | ALEXION PHARMACEUTICALS INC Financials
EDGAR Online Financials (Fri, May 15)
|
Add ALXN News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
